ISRCTN12081042CompletedNot Applicable
A pilot study to investigate whether patients with type 1 diabetes receiving insulin pump therapy have reduced markers of oxidative stress and cardiovascular risk compared to those on multiple daily injections
niversity of the Highlands and Islands (UK)0 sites48 target enrollmentStarted: September 9, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 48
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Patients with type 1 diabetes
- •2. Group A: patients not on insulin pump therapy and not on statin n=12
- •3. Group B: patients not on insulin pump therapy, but on statin n=12
- •4. Group C: patients on insulin pump therapy > 6 months and not on a statin n=12
- •5. Group D: patients on insulin pump therapy > 6 months and on a statin n=12
Exclusion Criteria
- •1. Type 2 diabetes
- •2. Very poor glucose control (HbA1c > 84 mmol/mol (10%)
- •3. Renal impairment (eGFR < 60ml/min/kg)
- •4. Recently diagnosed patients (<5 years)
- •5. Smokers or recently stopped (<6 months) ex-smokers
- •6. Chronic inflammatory disease (e.g. rheumatoid arthritis, Inflammatory bowel disease, asthma, chronic obstructive pulmonary disease)
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Study to investigate the effect of AP301 on treatment of primary graft dysfunction (PGD) after primary lung transplantatioEUCTR2013-000716-21-ATApeptico Forschung und Entwicklung GmbH
Recruiting
Not Applicable
Outcome of critically ill patients with abnormal sodium levels undergoing slow low efficiency daily dialysis therapyCTRI/2022/06/043320King George Medical University
Not yet recruiting
Not Applicable
The effect of Amlamax (made from Indian gooseberry) on raising good cholesterol.ACTRN12611000432910Prof Ralph Martins167
Not yet recruiting
Phase 2
Study to check the efficacy of Panchakarma procedures in the management of Multiple sclerosisCTRI/2024/03/064562All India Institute of Ayurveda
Active, not recruiting
Not Applicable
A pilot clinical trial to evaluate the ability of pegylate r-metHg-CSF (Pegilgrastim) to accelerate haematology recovery of patients with Non-Hodgkins Lymphoma after High-dose chemiotherapy and autologous stem cell transplantation.Patients with - risk Non-Hodgkin's Lymphoma in complete or partial response who underwent autologous PBPC transplantation after high-dose chemiotherapy.MedDRA version: 6.1Level: HLTClassification code 10012819EUCTR2005-004442-14-ITIVERSITA' DEGLI STUDI DI UDINE